Viewing Study NCT03497806

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 5:24 PM
Ignite Modification Date: 2026-01-10 @ 4:06 AM
Study NCT ID: NCT03497806
Status: COMPLETED
Last Update Posted: 2022-08-30
First Post: 2018-04-06
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection
Sponsor: Finch Research and Development LLC.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Clostridium Difficile Infection View
None Recurrent Clostridium Difficile Infection View
None C. Diff View
None CDI View
None Recurrent C. Diff View
None rCDI View
None C. Difficile View
None Recurrent CDI View
None FMT View
None Fecal Microbiota View
None Fecal Transplant View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Clostridium Difficile Infection View
None CP101 View
None Crestovo View
None FMT View
None CDI View
None C. difficile View
None C. diff View
None Recurrent Clostridium Difficile Infection View
None Recurrent C. diff View
None Recurrent CDI View
None Finch View
None Fecal transplant View
None Fecal microbiota transplant View
None rCDI View
None Finch Therapeutics View